Page 1 of Clinical Trials for Parkinsons Disease With End of Dose Wearing Off, 24 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Completed
An Extension Study of Entacapone in Patients With Parkinson's Disease With End-of-dose Wearing-off. This Study is Not Recruiting in the United States
Last Updated: November 22, 2011
Condition(s): Parkinson's Disease
2
Completed
Effects of Carbidopa/Levodopa/Entacapone on Motor Function and Quality of Life in Patients With Parkinson's Disease
Last Updated: February 16, 2011
Condition(s): Parkinson's Disease With End of Dose "Wearing Off"
3
Recruiting
Safety and Efficacy Study of SYN115 in Parkinson's Patients Using Levodopa to Treat End of Dose Wearing Off
Last Updated: March 1, 2012
Condition(s): Parkinson's Disease
4
Withdrawn
Carbidopa/Levodopa Versus Carbidopa/Levodopa/Entacapone on Markers of Event Related Potentials (ERPs) in Patients With Idiopathic Parkinson's Disease (PD) and End-of-dose Wearing Off
Last Updated: April 27, 2012
Condition(s): Parkinson's Disease
5
Completed
A Study to Explore the Safety And Tolerability of Doses of E2007 Up to a Maximum of 6 mg In Patients With Parkinson's Disease Who Experience End-of-Dose Wearing Off Motor Fluctuations
Last Updated: April 24, 2010
Condition(s): Parkinson's Disease
6
Completed
Study of KW-6002 (Istradefylline) for the Treatment of Parkinson's Disease in Patients Taking Levodopa
Last Updated: May 23, 2012
Condition(s): Parkinson's Disease
7
Completed
A Study of Istradefylline (KW-6002) for the Treatment of Parkinson's Disease in Patients Taking Levodopa
Last Updated: June 22, 2010
Condition(s): Parkinson's Disease
8
Completed
A Phase 2b Study of Istradefylline (KW-6002) for the Treatment of Parkinson's Disease in Patients Taking Levodopa
Last Updated: May 23, 2012
Condition(s): Parkinson's Disease
9
Completed
A Study of Istradefylline (KW-6002) for the Treatment of Parkinson's Disease in Patients Taking Levodopa
Last Updated: May 23, 2012
Condition(s): Parkinson's Disease
10
Completed
A Study of Istradefylline (KW-6002) in Treating Patients With Parkinson's Disease on Levodopa
Last Updated: June 22, 2010
Condition(s): Parkinson's Disease
11
Completed
12-Week, Double-Blind, Placeob-Controlled Study of 20 and 60 mg/Day Istradefylline in Parkinson's Disease Patients on Levodopa/Carbodopa
Last Updated: June 22, 2010
Condition(s): Parkinson's Disease
12
Completed
Long-Term Safety Study of KW-6002 (Istradefylline) in Parkinson's Disease Patients
Last Updated: May 23, 2012
Condition(s): Parkinson's Disease
13
Completed
12-Week, Double-Blind, Placebo-Controlled, Randomized Study of the Efficacy of 40 mg/Day KW-6002 in Parkinson's Disease Patients on Levodopa/Carbidopa
Last Updated: June 22, 2010
Condition(s): Parkinson's Disease
14
Completed
An Extension of Istradefylline in Parkinson's Disease Patients Who Have Completed Studies 6002-EU-007, 6002-US-013 or 6002-US-018
Last Updated: June 22, 2010
Condition(s): Parkinson's Disease
15
Terminated
An Extension of Istradefylline in North American Parkinson's Disease Patients Who Have Completed Study 6002-INT-001
Last Updated: April 20, 2011
Condition(s): Parkinson's Disease
16
Terminated
Carbidopa/Levodopa/Entacapone Versus Immediate Release (IR) Carbidopa/Levodopa on Non-motor Symptoms in Patients With Idiopathic Parkinson's Disease and Demonstrating Non-motor Symptoms of Wearing Off
Last Updated: February 16, 2011
Condition(s): Parkinson's Disease
17
Completed
Safety and Efficacy Study of Fipamezole in Treatment of Motor Dysfunctions in Parkinson's Disease
Last Updated: June 2, 2009
Condition(s): Parkinson's Disease
18
Terminated
A Study of E2007 In Patients With Parkinson's Disease
Last Updated: May 7, 2008
Condition(s): Parkinson's Disease
19
Recruiting
Efficacy and Safety of BIA 9-1067 in Idiopathic Parkinson's Disease Patients With "Wearing-off" Phenomenon
Last Updated: March 30, 2012
Condition(s): Parkinson's Disease
20
Terminated
Evaluation of the Long-Term Safety, Tolerability, and Efficacy of Perampanel (E2007) as an Adjunctive Therapy in Levodopa Treated Parkinson's Disease Subjects With Motor Fluctuations
Last Updated: May 7, 2008
Condition(s): Parkinson's Disease

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=Parkinsons+Disease+With+End+of+Dose+Wearing+Off

Page 1 of Clinical Trials for Parkinsons Disease With End of Dose Wearing Off, 24 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About